Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068829
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-05
First Post:
2023-09-29
Brief Title:
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders
Sponsor:
Feng Jinzhou
Organization:
First Affiliated Hospital of Chongqing Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-29
First Submit QC Date:
September 29 2023
Study First Post Date:
2023-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-29
Last Update Post Date:
2023-10-05
Last Update Post Date Type:
ACTUAL